Case report: Mechanical mitral prosthetic valve thrombosis in the context of COVID-19 despite effective anticoagulation.
Clarisse JeckelmannBojan DjokicValérie DuchatelleGrégoire GirodPublished in: European heart journal. Case reports (2022)
The pro-coagulant effect of the SARS-CoV2 virus does not spare patients at risk of thrombosis, even under effective anticoagulation. In patients with mechanical valves under vitamin K antagonist treatment, there is a high risk of thrombus formation. The treatment is based on thrombolysis by therapeutic anticoagulation, fibrinolysis, or surgery depending on the size, composition of thrombus, and clinical manifestation.
Keyphrases
- sars cov
- pulmonary embolism
- atrial fibrillation
- venous thromboembolism
- case report
- mitral valve
- aortic valve
- coronavirus disease
- minimally invasive
- aortic stenosis
- heart failure
- respiratory syndrome coronavirus
- coronary artery bypass
- replacement therapy
- transcatheter aortic valve replacement
- left atrial
- anti inflammatory
- ejection fraction